Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer: a meta-analysis and systemic review of randomized clinical trials
Wenjie Zhu, Binghe Xu
Topics & Concepts
Human Epidermal Growth Factor Receptor 2Breast cancerMedicineOncologyInternal medicineSystemic therapyRandomized controlled trialMeta-analysisCancerEndocrine systemHormone receptorHormoneAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesCancer-related Molecular Pathways